Ticker: BOLD

Boundless Bio, Inc. (NASDAQ: BOLD) has recently released its financial results for the first quarter of 2025. The company is focused on developing innovative oncology treatments targeting oncogene amplified cancers through its platform, Spyglass, and expects to generate significant data from its ...